Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.
An oral antiviral drug by Merck & Co. has joined the armamentarium of the pharmacological fight against COVID-19.
Molnupiravir pills by Merck & Co. can help COVID-19 patients avoid going to the hospital or dying.
FDA scientists took a detailed look at molnupiravir for treating COVID-19.
The oral antiviral drug molnupiravir by Merck & Co.